Only several publications have concerned the evaluation of the utility of measurements of VEGF, MMP-2, MMP-9, TIMP-1, and YKL-40 in serum in melanoma; what is more, the results are controversial [10–17]. The gene discussed is MMP9; the disease is melanoma.